Skip to main content
    L

    Lantern Pharma Inc (LTRN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.36
    -0.02 (-6.17%)

    Market Cap: $5.81M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Lantern Pharma Inc (LTRN) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Lantern Pharma (LTRN) has a latest price of $0.36 on Nov 17, 2026. Its price fell 89.2% over the past 12 months. The month-end price fell 93.5% over the 5 years through Oct 2026, a compound annual decline of 42.2%.

    Price Chart

    From Jun 2020 to Oct 2026, its highest month-end close was $19.25 in Dec 2020 and its lowest $0.66 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart LTRN with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for LTRN.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 85.3%, and over 6 months it fell 88.2%. The month-end price fell 73.4% over the 3 years through Oct 2026, a compound annual decline of 35.7%.

    PeriodChange
    1 month-43.1%
    3 months-85.3%
    6 months-88.2%
    12 months-89.2%
    12 months, with dividends-89.2%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-73.4%-35.7%
    5 years-93.5%-42.2%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price fell 5.0%, and its weakest was 2021, when it fell 58.5%.

    YearCloseChange
    2026 through Oct 2026$0.66-78.2%
    2025$3.03-5.0%
    2024$3.19-25.5%
    2023$4.28-29.1%
    2022$6.04-24.3%
    2021$7.98-58.5%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 60.6% below its 50-day average of $0.93 and 84.1% below its 200-day average of $2.29.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.36
    50-day average$0.93-60.6%
    200-day average$2.29-84.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 96.6%.

    MeasureValue
    1-year beta3.04
    Largest fall, 1 year-91.2%
    Largest fall, 3 years-96.6%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About LTRN

    What is LTRN's 1-year price change?

    Lantern Pharma's price fell 89.2% over the past 12 months. With dividends included, the 12-month total return was -89.2%.

    What is LTRN's 5-year price change?

    Lantern Pharma's month-end price fell 93.5% over the 5 years through Oct 2026, a compound annual decline of 42.2%. These figures leave out dividends.

    What is LTRN's beta?

    Lantern Pharma's 1-year beta against the S&P 500 is 3.04, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 91.2%.

    Is the LTRN chart free?

    Yes. Advanced Charting for LTRN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.